Board of Trustees


WILLIAM WOOD ALLEN
Chief Executive Officer
WoodAllen Capital Management, LLC

PETER S. AMENTA, M.D., Ph.D.*
Dean
UMDNJ-Robert Wood Johnson Medical School

SUBHA V. BARRY - Chair

THOMAS A. BRACKEN
President
TriState Capital Bank

ROBERT E. CAMPBELL
Chair, CINJ Advisory Council
Johnson & Johnson, Vice Chairman (Retired)

ROBERT S. DiPAOLA, M.D.*
Director
The Cancer Institute of New Jersey
Professor of Medicine
UMDNJ, Robert Wood Johnson Medical School

JEFFREY N. EDWARDS
Partner
New Vernon Capital, LLC

AUDREY GOULD
Senior Vice President
The Gould Group of Wachovia Securities

WILLIAM N. HAIT, M.D., Ph.D.
Senior Vice President
Worldwide Head of Hematology/Oncology Research and Development
Johnson & Johnson Pharmaceutical Research and Development, LLC

RONALD J. LEVINE, Esq.
Partner
Herrick, Feinstein, LLP, Newark, NJ

DUNCAN L. MacMILLAN
Co-Founder
Bloomberg LP

PAUL MIGNON
President and Chief Operating Officer
Ventiv Pharma Teams
inVentiv Commercial Services

MICHELLE MORTON
President and Chief Executive Officer
Pacific American Securities, LLC

DENISE V. RODGERS, MD
Executive Vice President for Academic and Clinical Affairs
University of Medicine and Dentistry of New Jersey

RICHARD C. ROSENZWEIG, Esq.
Associate General Counsel
C.R. Bard, Inc.

LESLIE LOGAN TAYLOR
Partner
Matrix Development Group

JOHN R. WHITMAN
Managing Partner
Sycamore Management Corporation

ARSHAD R. ZAKARIA
President and Chief Executive Officer
New Vernon Capital, LLC


*Ex-Officio